Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis
Authors:
- 22 March 2022
- journal article
- review article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 54 (6) , 713-721
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta‐analysisUnited European Gastroenterology Journal, 2021
- SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statementThe Lancet Gastroenterology & Hepatology, 2021
- Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 PandemicGastroenterology, 2021
- COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of GastroenterologyJournal of the Canadian Association of Gastroenterology, 2021
- SARS-CoV-2 vaccination in IBD: more pros than consNature Reviews Gastroenterology & Hepatology, 2021
- SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meetingGut, 2021
- Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concernsDigestive and Liver Disease, 2020
- How to perform a meta-analysis with R: a practical tutorialEvidence Based Mental Health, 2019
- Conducting Meta-Analyses inRwith themetaforPackageJournal of Statistical Software, 2010
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000